CAIRO PHARMACEUTICALS
CPCI
EGX
Current Price
EGP
EGP (%)
Price Upon Recommendation
166.16 EGP
Target Price from Recommendation
180.00 EGP
+8.30%Holding Period
From 3 to 6 months
Final Recommendation
Buy stock at the current price
Valid Until
July 16, 2025 at 11:59:59 PM
Risk Assessment
Medium
Confidence Score
85.00%
Potential Growth
12.50%
Investment Reason
CPCI has demonstrated strong recent performance and aligns with Egypt's economic recovery trends, supported by its competitive positioning in high-demand sectors.
Overview
Recent Performance
CPCI's price surged 6.4% over the past month, outperforming the EGX 30 index.
Economic Factors
Egypt's inflation stabilization and EGX's resilience amid regional tensions support growth prospects.
Competitive Positioning
CPCI operates in sectors benefiting from infrastructure growth and consumer demand, with strong liquidity metrics.
Analysis Summary
CPCI is poised for growth driven by sectoral tailwinds and favorable economic conditions, with a realistic target price achievable within Q3 2025.
Key Points
- 6.4% monthly gain outperforming EGX 30 index.
- Strong liquidity and sectoral tailwinds in infrastructure/consumer goods.
- 12.5% growth potential aligned with Egypt's economic recovery.
- Realistic Q3 2025 target price of 180.00 EGP.
